EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care

Ahmad Alam

Bangladesh Journal of Endocrinology and Metabolism · 2026-09 · 5 (3) · 336-340

DOI: 10.4103/bjem.bjem_17_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bangladesh Journal of Endocrinology and Metabolism, online erschienen am 15.05.2026. Verfasst von Ahmad Alam. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alam, A. (2026). Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care. Bangladesh Journal of Endocrinology and Metabolism, 5(3), 336-340. https://doi.org/10.4103/bjem.bjem_17_26

Vancouver

Alam A. Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care. Bangladesh Journal of Endocrinology and Metabolism. 2026;5(3):336-340. doi:10.4103/bjem.bjem_17_26

BibTeX
@article{Alam2026,
  author = {Alam, Ahmad},
  title = {Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care},
  journal = {Bangladesh Journal of Endocrinology and Metabolism},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {336--340},
  doi = {10.4103/bjem.bjem_17_26}
}
Kostenlos starten →